Coastlands Capital adds to ADIAL Pharmaceuticals stake

Coastlands Capital LP, a ten percent owner of ADIAL PHARMACEUTICALS, INC., reported two open-market purchases of ADIL common stock.

Rhea-AI Filing Summary

Coastlands Capital LP, a ten percent owner of ADIAL PHARMACEUTICALS, INC., reported two open-market purchases of ADIL common stock. On July 9, 2026 it bought 10,053 shares at $2.79 per share, and on July 10, 2026 it bought 1,700 shares at $2.70 per share.

After these transactions, Coastlands Capital LP held 385,075 shares of ADIL common stock, reported as indirect ownership "By Coastlands Capital LP." A joint reporting footnote explains that several related entities and Matthew Perry are filing together and each disclaims beneficial ownership beyond their pecuniary interest.

Filing Explained

The disclosed indirect position reaches 385,075 shares after two open-market purchases by a 10% owner.

The July 13, 2026 Form 4 reports that Coastlands Capital LP, a 10% owner, completed open-market purchases of 10,053 shares on July 9, 2026 and 1,700 shares on July 10, 2026, with 385,075 shares beneficially owned indirectly after the reported transactions.

Under the supplied Form 4 definitions, transaction code P means an open-market purchase; the reported securities were common stock acquired at $2.79 and $2.70 per share and held indirectly through Coastlands Capital LP.

The explanation limits each reporting person's beneficial ownership to its pecuniary interest and states that the joint filing does not make the reporting persons members of a group.

The supplied 90-day platform record lists 73,131 shares bought, zero shares sold, and four transactions in the covered insider activity.

Insider Trade Summary

Net Buyer: 11,753 shares

Net Buy 2 txns

Insider Coastlands Capital LP

Role 10% Owner

Bought 11,753 shs ($33K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	1,700	$2.70	$5K
Purchase	Common Stock F1	10,053	$2.79	$28K

Holdings After Transaction: Common Stock — 385,075 shares (Indirect, By Coastlands Capital LP)

Footnotes (1)

1. F1. Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

Key Figures

Shares purchased July 9, 2026: 10,053 shares Price per share July 9, 2026: $2.79 Shares purchased July 10, 2026: 1,700 shares +3 more

6 metrics

Shares purchased July 9, 2026 10,053 shares Open-market purchase of ADIL common stock at $2.79 per share

Price per share July 9, 2026 $2.79 Purchase price for 10,053 ADIL shares in open-market transaction

Shares purchased July 10, 2026 1,700 shares Open-market purchase of ADIL common stock at $2.70 per share

Price per share July 10, 2026 $2.70 Purchase price for 1,700 ADIL shares in open-market transaction

Total shares purchased 11,753 shares Combined open-market purchases reported in this Form 4

Shares held after transactions 385,075 shares Indirect ADIL common stock holdings "By Coastlands Capital LP" after purchases

Key Terms

open-market purchase, ten percent owner, indirect ownership, pecuniary interest

4 terms

open-market purchase financial

"transaction_action is described as an open-market purchase of common stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner financial

"Coastlands Capital LP is identified as a ten percent owner of the issuer"

indirect ownership financial

"total shares are reported as indirect ownership "By Coastlands Capital LP""

pecuniary interest financial

"each reporting person disclaims beneficial ownership except to the extent of pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Coastlands Capital LP report for ADIL?

Coastlands Capital LP reported two open-market purchases of ADIAL PHARMACEUTICALS (ADIL) common stock, totaling 11,753 shares at prices of $2.79 and $2.70 per share, increasing its indirect holdings.

How many ADIL shares did Coastlands Capital LP buy on July 9, 2026?

On July 9, 2026, Coastlands Capital LP bought 10,053 shares of ADIL common stock at $2.79 per share in an open-market purchase, as reported in the Form 4 filing for indirect ownership.

What was the second ADIL share purchase reported by Coastlands Capital LP?

On July 10, 2026, Coastlands Capital LP completed another open-market purchase of 1,700 ADIL shares at $2.70 per share, adding to its previously reported indirect holdings in ADIAL PHARMACEUTICALS.

What are Coastlands Capital LP’s ADIL holdings after these transactions?

Following the reported purchases, Coastlands Capital LP’s indirect holdings in ADIL common stock total 385,075 shares, shown in the Form 4 as held "By Coastlands Capital LP" with indirect ownership status.

How does the Form 4 describe Coastlands Capital LP’s ownership structure in ADIL?

The Form 4 notes Coastlands Capital LP as a ten percent owner of ADIL. A footnote explains that related entities and Matthew Perry file jointly and each disclaims beneficial ownership except to the extent of their pecuniary interest.

Were there any ADIL share sales or derivative exercises in this Form 4?

No. The Form 4 for ADIL reports only net open-market purchases by Coastlands Capital LP totaling 11,753 shares, with no sales or derivative exercises disclosed in the transaction summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 10:30 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coastlands Capital LP

(Last) (First) (Middle)

601 CALIFORNIA STREET

SUITE 1210

(Street)

SAN FRANCISCO CALIFORNIA 94108

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ADIAL PHARMACEUTICALS, INC. [ ADIL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/09/2026		P		10,053	A	$2.79	383,375	I	By Coastlands Capital LP(1)
Common Stock	07/10/2026		P		1,700	A	$2.7	385,075	I	By Coastlands Capital LP(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

	/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP	07/13/2026
	/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital Partners LP	07/13/2026
	/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital GP LLC	07/13/2026
	/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital LLC	07/13/2026
	/s/ Matthew D. Perry	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)